Evidence map›Paper›PMID 36532727›Full record

ArticleFrontiers in pharmacology2022

Impact of fluvoxamine on outpatient treatment of COVID-19 in Honduras in a prospective observational real-world study.

Estela Pineda, Jarmanjeet Singh, Miguel Vargas Pineda, Jose Garay Umanzor, Fernando Baires, Luis G Benitez, Cesar Burgos, Anupamjeet Kaur Sekhon, Nicole Crisp, Anita S Lewis and 14 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 2 pooled it
0.6field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 syntheses or guidelines pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Efficacy and safety of selective serotonin reuptake inhibitors in COVID-19 management: a systematic review and meta-analysis.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2023
    Pooled it
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors at 6 institutions in 2 countries.

Estela PinedaDepartment of Internal Medicine Hospital CEMESA, San Pedro Sula, Honduras.
Jarmanjeet SinghDepartment of Cardiovascular Medicine, University of California, Riverside, Riverside, CA, United States.
Miguel Vargas PinedaDepartment of Internal Medicine Hospital Mario Catarino Rivas, San Pedro Sula, Honduras.
Jose Garay UmanzorDepartment of Obstetrics and Gynecology Hospital Mario Catarino Rivas, San Pedro Sula, Honduras.
Fernando BairesUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Luis G BenitezUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Cesar BurgosUniversidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Anupamjeet Kaur SekhonSleep Medicine, Kaiser Permanente, Fontana, CA, United States.
Nicole CrispWound Care Department El Campo Memorial Hospital, El Campo, TX, United States.
Anita S LewisPharmacy Department El Campo Memorial Hospital, El Campo, TX, United States.
Jana RadwanskiPharmacy Department Citizens Hospital, Victoria, TX, United States.
Marco BermudezDepartment of Medicine SBH Health System, Bronx, NY, United States.
Karen Sanchez BarjunDepartment of Internal Medicine Hospital Mario Catarino Rivas, San Pedro Sula, Honduras.
Oscar DiazDepartment of Critical Care Hospital Regional del Norte Instituto Hondureño de Seguridad Social, San Pedro Sula, Honduras.
Elsa PalouInternal Medicine Department, Facultad de Ciencas Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Rossany E EscalanteDepartment of Medicine, Facultad de Ciencas Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Carlos Isai HernandezHEME Clinic, Choluteca, Honduras.
Mark L StevensResearch Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States.
Deke EberhardResearch Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States.
Manuel SierraUniversidad Tecnológica Centroamericana, Tegucigalpa, Honduras.
Tito AlvaradoInfectiology Department, Facultad de Ciencias Médicas, Universidad Nacional Autónoma de Honduras, Tegucigalpa, Honduras.
Omar VideaClínica de Atención Medica Integral CAMI, Tegucigalpa, Honduras.
Miguel Sierra-HoffmanResearch and Infectious Disease Department, Texas A&M College of Medicine, Detar Family Medicine Residency Program, Victoria, TX, United States.
Fernando Valerio-PascuaDepartment of Critical Care Hospital CEMESA, San Pedro Sula, Honduras.
Honduras Foundation for Agricultural Research · HNNational Autonomous University of Honduras · HNMemorial Hospital · USCentral American Technological University · HNKaiser Permanente Fontana Medical Center · USUniversity of California, Riverside · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19early outpatient treatmentfluvoxamineHondurasrepurposed drugs

Identifiers

PMID36532727
PMCPMC9748291
OpenAlexW4310481531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.